RT Journal Article
SR Electronic
T1 The Potential Blood Pressure Lowering Benefit of Azilsartan Medoxomil
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 5
SP 11
OP 11
DO 10.1177/155989771005009
UL http://mdc.sagepub.com/content/10/5/11.abstract
AB This article discusses findings from this phase III, multicenter, parallel-group, double-blind, randomized placebo-and active-controlled trial [NCT00696241]. The purpose of this study was to compare the BP lowering effects of azilsartan medoxomil with olmesartan medoxomil and placebo over a period of 6 weeks in patients with primary hypertension.